• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T细胞亚群与细胞因子在炎症性肠病免疫发病机制中的作用

The Business of T Cell Subsets and Cytokines in the Immunopathogenesis of Inflammatory Bowel Disease.

作者信息

Bharti Shreekant, Bharti Mridushri

机构信息

Pathology/Laboratory Medicine, All India Institute of Medical Sciences Patna, Patna, IND.

Microbiology, Netaji Subhas Medical College and Hospital, Patna, IND.

出版信息

Cureus. 2022 Jul 26;14(7):e27290. doi: 10.7759/cureus.27290. eCollection 2022 Jul.

DOI:10.7759/cureus.27290
PMID:36039239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9407026/
Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder and one of the most common inflammatory diseases of gastrointestinal (GI) tract in young adults. It is now equally prevalent in western countries as well as in Asian countries. Recently, there has been an increasing IBD burden in low- to middle-income countries as opposed to the earlier notion of this being a disease of the affluents. It occurs due to a variety of factors, namely, local immune alteration, disruption and inflammation of the mucosa, environmental factors, microbial commensals, and pathogen-induced genetic predisposition or genetic alteration in protective factors, etc. So far, an exact etiopathogenesis of IBD is yet to be completely elucidated. Several recent types of research have emphasized the role of altered innate and humoral immunity in its causation, many of them based on animal models of IBD. Due to the poor understanding of its etiopathogenesis, IBD is still a challenge for the treating clinicians leading to persistent and recurrent disease in many cases. Immune dysregulation in the GI tract incited by various pathogenic stimuli has gained great attention from researchers in the field of IBD. This review focuses on highlighting the role of various T cell subsets, their interplay, and associated cytokines involved in the pathogenesis of IBD along with a short description of genetic as well as other immunological factors. A better understanding of the pathogenic factors and subsequent randomized controlled trials targeting these factors is prudent for better therapeutic approaches for IBD.

摘要

炎症性肠病(IBD)是一种慢性炎症性疾病,是年轻成年人中最常见的胃肠道(GI)炎症性疾病之一。目前在西方国家和亚洲国家中同样普遍。最近,低收入和中等收入国家的IBD负担不断增加,这与之前认为该病是富裕人群疾病的观念相反。它是由多种因素引起 的,即局部免疫改变、黏膜破坏和炎症、环境因素、微生物共生体以及病原体诱导的遗传易感性或保护因子中的基因改变等。到目前为止,IBD的确切病因发病机制尚未完全阐明。最近的几项研究强调了先天性和体液免疫改变在其病因中的作用,其中许多研究基于IBD动物模型。由于对其病因发病机制了解不足,IBD对治疗临床医生来说仍然是一项挑战,在许多情况下会导致疾病持续和复发。胃肠道中由各种致病刺激引发的免疫失调已引起IBD领域研究人员的高度关注。本综述重点强调各种T细胞亚群的作用、它们之间的相互作用以及参与IBD发病机制的相关细胞因子,并简要描述遗传以及其他免疫因素。更好地了解致病因素并随后针对这些因素进行随机对照试验,对于IBD更好的治疗方法来说是明智的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5df/9407026/c91080fd37df/cureus-0014-00000027290-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5df/9407026/c91080fd37df/cureus-0014-00000027290-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5df/9407026/c91080fd37df/cureus-0014-00000027290-i01.jpg

相似文献

1
The Business of T Cell Subsets and Cytokines in the Immunopathogenesis of Inflammatory Bowel Disease.T细胞亚群与细胞因子在炎症性肠病免疫发病机制中的作用
Cureus. 2022 Jul 26;14(7):e27290. doi: 10.7759/cureus.27290. eCollection 2022 Jul.
2
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
3
Immunological pathogenesis of inflammatory bowel disease.炎症性肠病的免疫发病机制
Intest Res. 2018 Jan;16(1):26-42. doi: 10.5217/ir.2018.16.1.26. Epub 2018 Jan 18.
4
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.《2018年炎症性肠病在加拿大的影响:患有炎症性肠病的儿童和青少年》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.
5
Dysregulation of T cell response in the pathogenesis of inflammatory bowel disease.T 细胞反应失调在炎症性肠病发病机制中的作用。
Scand J Immunol. 2024 Dec;100(6):e13412. doi: 10.1111/sji.13412. Epub 2024 Oct 12.
6
Innate and adaptive immunity in inflammatory bowel disease.炎症性肠病中的先天免疫和适应性免疫。
Autoimmun Rev. 2014 Jan;13(1):3-10. doi: 10.1016/j.autrev.2013.06.004. Epub 2013 Jun 15.
7
Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease.炎症性肠病发病机制中遗传易感性、肠道微生物群和宿主免疫反应之间的关联。
Braz J Med Biol Res. 2014 Sep;47(9):727-37. doi: 10.1590/1414-431x20143932. Epub 2014 Jul 25.
8
Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies.炎症性肠病的免疫发病机制及生物治疗机制
Scand J Gastroenterol. 2018 Apr;53(4):379-389. doi: 10.1080/00365521.2018.1447597. Epub 2018 Mar 9.
9
Biologic therapy for inflammatory bowel disease.炎症性肠病的生物治疗
Drugs. 2005;65(16):2253-86. doi: 10.2165/00003495-200565160-00002.
10
The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.《2018年炎症性肠病在加拿大的影响:流行病学》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2.

引用本文的文献

1
Combination of Youhua Kuijie Prescription and sulfasalazine can alleviate experimental colitis via IL-6/JAK2/STAT3 pathway.优化溃结方与柳氮磺胺吡啶联合应用可通过IL-6/JAK2/STAT3信号通路减轻实验性结肠炎。
Front Pharmacol. 2024 Sep 10;15:1437503. doi: 10.3389/fphar.2024.1437503. eCollection 2024.
2
Cytokine Profile in Predicting the Effectiveness of Advanced Therapy for Ulcerative Colitis: A Narrative Review.细胞因子谱在预测溃疡性结肠炎高级治疗效果中的应用:一项叙述性综述
Biomedicines. 2024 Apr 25;12(5):952. doi: 10.3390/biomedicines12050952.
3
Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases.

本文引用的文献

1
Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice.将 Treg 疗法用于人源化小鼠的炎症性肠病研究。
Cells. 2021 Jul 21;10(8):1847. doi: 10.3390/cells10081847.
2
Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.肠道通透性增加与克罗恩病的后期发展有关。
Gastroenterology. 2020 Dec;159(6):2092-2100.e5. doi: 10.1053/j.gastro.2020.08.005. Epub 2020 Aug 10.
3
Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease.
炎症性肠病中的炎症、自身炎症和自身免疫
Curr Issues Mol Biol. 2023 Jun 30;45(7):5534-5557. doi: 10.3390/cimb45070350.
细胞因子回路与转录调控在炎症性肠病中塑造辅助性 T 细胞的致病性和可塑性的相互作用。
Int J Mol Sci. 2020 May 11;21(9):3379. doi: 10.3390/ijms21093379.
4
Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD.剖析 IBD 中 T 细胞介导炎症的异质性。
Cells. 2020 Jan 2;9(1):110. doi: 10.3390/cells9010110.
5
Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells.肠道微生物群对肠道远端自身免疫的影响:以 T 细胞为重点。
Immunology. 2019 Apr;156(4):305-318. doi: 10.1111/imm.13037. Epub 2019 Jan 21.
6
Immunological pathogenesis of inflammatory bowel disease.炎症性肠病的免疫发病机制
Intest Res. 2018 Jan;16(1):26-42. doi: 10.5217/ir.2018.16.1.26. Epub 2018 Jan 18.
7
Fine-mapping inflammatory bowel disease loci to single-variant resolution.将炎症性肠病基因座精细定位到单变体分辨率。
Nature. 2017 Jul 13;547(7662):173-178. doi: 10.1038/nature22969. Epub 2017 Jun 28.
8
Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis.调节性T细胞和叉头框蛋白3作为免疫稳态的调节因子
Front Immunol. 2017 May 26;8:605. doi: 10.3389/fimmu.2017.00605. eCollection 2017.
9
Inflammatory Bowel Disease in Childhood and Adolescence.儿童和青少年炎症性肠病。
Dtsch Arztebl Int. 2017 May 12;114(19):331-338. doi: 10.3238/arztebl.2017.0331.
10
Homeostatic Immunity and the Microbiota.稳态免疫与微生物群
Immunity. 2017 Apr 18;46(4):562-576. doi: 10.1016/j.immuni.2017.04.008.